Showing results (121-130 of 296) with videos related to

Sort By:
Pageof 30
Cancer|May 5, 2016
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studiesHagop M Kantarjian, Anthony S Stein, Ralf C Bargou, et al.
Journal of the American Heart Association|June 2, 2016
High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry DiseaseNora Seydelmann, Dan Liu, Johannes Krämer, et al.
Basic Research in Cardiology|July 2, 2013
5-Lipoxygenase facilitates healing after myocardial infarctionNadja Blömer, Christina Pachel, Ulrich Hofmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CTJohannes Duell, Franziska Krummenast, Andreas Schirbel, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Blood|July 14, 2010
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantationTobias Feuchtinger, Kathrin Opherk, Wolfgang A Bethge, et al.
Blood|August 2, 2015
Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCLFritz Offner, Olga Samoilova, Evgenii Osmanov, et al.
Radiology|November 14, 2014
Myocardial T1: quantification by using an ECG-triggered radial single-shot inversion-recovery MR imaging sequenceDaniel Gensler, Philipp Mörchel, Florian Fidler, et al.
The American Journal of Case Reports|June 29, 2017
Double Peripheral Venous and Arterial Cannulation for Extracorporeal Membrane Oxygenation in Combined Septic and Cardiogenic ShockMarkus Kredel, Steffen Kunzmann, Paul-Gerhardt Schlegel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2023
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [18F]FDGAleksander Kosmala, Johannes Duell, Simone Schneid, et al.
Pageof 30